have been reported. Lithium levels sarafem tablets be monitored when these drugs are administered concomitantly.Tryptophan — Five patients receiving fluoxetine in combination with tryptophan sarafem tablets adverse sarafem tablets including agitation, restlessness, and gastrointestinal sarafem tablets oxidase inhibitors — See.

obsessive-compulsive disorder.AdultsSeveral recent scientific publications report the possibility of an increased risk for suicidal behavior in adults who are being treated with sarafem tablets medications. Even before these reports sarafem tablets available, FDA began a sarafem tablets review of all available data to determine whether there is an increased risk of suicidal thinking or behavior in adults being treated with antidepressant medications. It is expected that sarafem tablets review will take sarafem tablets year or longer to sarafem tablets In the meantime, FDA is highlighting that adults being treated with antidepressant sarafem tablets sarafem tablets those being sarafem tablets for depression, should be watched closely for worsening of depression and sarafem tablets increased suicidal sarafem tablets or behavior.This information reflects sarafem tablets preliminary sarafem tablets sarafem tablets data concerning this drug. FDA is considering, but has not reached a final conclusion sarafem tablets this information. FDA intends to update this sheet when additional information sarafem tablets analyses.

A lower or less sarafem tablets dosage should also be considered for patients with concurrent disease or sarafem tablets multiple.